The Mardis Aibel "Biotechnology Management Practices" Study
Progenta and Mardis Aibel (New York; www.mardisaibel.com) are working together to improve the performance of life science and related companies.
During 2003, Mardis Aibel performed, what is to our knowledge, the only comprehensive survey of management practices and performance in Biotech companies. They surveyed over 200 senior executives in almost 60 companies and also took opinion from leading independent investors, analysts, communication experts and recruiters.
The resulting 2-volume study offers for the first time an in depth study and practical roadmap for everyone involved in Biotech and related life science industries. It contains compelling data on how top organisations make things work and highlights the need to strengthen management skills and practices in most cases (when comparing performance to standard industrial best practices they found that only 6% of the companies involved met the basic requirements for success). The Study features:
 | Over 100 data analysis exhibits – information on how top firms make things work |
| The Mardis Aibel Biotechnology Management Lifecycle Model - with detailed commentary |
| Building efficient and effective executive teams |
| The role of the board and senior management |
| Best practices for key functions and activities |
| Case studies of leading firms – real stories on how they are overcoming the inevitable challenges |
| Candid advice from top investors, executive recruiters, and communication experts plus a how-to-guide for working with outsourcing partners |
| and much more..... |
The study is available In Europe exclusively through Progenta.
| Click here to request the Table of Contents, details of Participants, Contributors & Collaborators and receive purchase information |
| Click here to enquire about an on-site introductory presentation |
About Mardis Aibel
Mardis Aibel & Associates helps biotechnology and biopharmaceutical companies turn great strategies into great businesses. We develop and implement practical solutions that overcome the unique management, operational, and organizational challenges that face executives in the life sciences industry.
The partners and consultants at Mardis Aibel bring decades of hands-on experience in dealing with the often vexing problems of execution; how to transition firms as they move from discovery to development, how to design a commercialization strategy; how to set performance goals and measure against them, how to reduce burn rates without jeopardizing performance, how to organize and manage an efficient and effective clinical development function.
Mardis Aibel’s practices over the full value chain of life science company operations from discovery, through clinical development and into commercialization. We address the total range of support functions including the organization and management of human resources, finance, business development, information technology, marketing and sales, and manufacturing and sourcing. For all areas, we offer organizational planning and change management, business process reengineering, and infrastructure alignment.